Cancer drug: Indian board rejects AstraZeneca's patent plea
India's patents appeal board has dismissed British drugmaker AstraZeneca's petition challenging an earlier ruling that refused patent protection for a cancer-fighting drug, in the latest blow for Big Pharma in the country.
Anda sedang membaca artikel tentang
Cancer drug: Indian board rejects AstraZeneca's patent plea
Dengan url
https://kesehatanda.blogspot.com/2012/11/cancer-drug-indian-board-rejects.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Cancer drug: Indian board rejects AstraZeneca's patent plea
namun jangan lupa untuk meletakkan link
Cancer drug: Indian board rejects AstraZeneca's patent plea
sebagai sumbernya
0 komentar:
Posting Komentar